Alzheimer's disease Archives - GEN - Genetic Engineering and Biotechnology News

Home 2024

FDA Approves Lilly’s Amyloid-Targeting Kisunla for Early Alzheimer’s

Drug Discovery

FDA Approves Lilly’s Amyloid-Targeting Kisunla for Early Alzheimer’s

Alzheimer’s Clue: Serotonin C Receptor Has Role in Memory Loss

Drug Discovery

Alzheimer’s Clue: Serotonin C Receptor Has Role in Memory Loss

Insilico Moves HQ to Cambridge, MA, Completes IPF Trial Enrollment

Artificial Intelligence

Insilico Moves HQ to Cambridge, MA, Completes IPF Trial Enrollment

Sex-Specific Parental History of Alzheimer’s Could Identify At-Risk Adults

Featured

Sex-Specific Parental History of Alzheimer’s Could Identify At-Risk Adults

Alzheimer’s Drug Developer Alzheon Closes $100M Series E Financing

Drug Discovery

Alzheimer’s Drug Developer Alzheon Closes $100M Series E Financing

StockWatch: Like a Bolt from the Blue, Cancer Drug Developer Nosedives

Cancer

StockWatch: Like a Bolt from the Blue, Cancer Drug Developer Nosedives

Alzheimer’s Type Identified That Involves Gene Variant Carried by 2% of Population

Featured

Alzheimer’s Type Identified That Involves Gene Variant Carried by 2% of Population

Neural Compass May Lead to Insights into Parkinson’s and Alzheimer’s Diseases

News

Neural Compass May Lead to Insights into Parkinson’s and Alzheimer’s Diseases

Another Phase III Trial Failure in Neuroscience: What Are We Doing Wrong?

Drug Discovery

Another Phase III Trial Failure in Neuroscience: What Are We Doing Wrong?

StockWatch: Biogen Q1 Results Beat Expectations, for a Change

Drug Discovery

StockWatch: Biogen Q1 Results Beat Expectations, for a Change

12 3...8 Page 1 of 8